» Articles » PMID: 35885015

Mouse Models for Application in Colorectal Cancer: Understanding the Pathogenesis and Relevance to the Human Condition

Overview
Journal Biomedicines
Date 2022 Jul 27
PMID 35885015
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is a malignant disease that is the second most common cancer worldwide. CRC arises from the complex interactions among a variety of genetic and environmental factors. To understand the mechanism of colon tumorigenesis, preclinical studies have developed various mouse models including carcinogen-induced and transgenic mice to recapitulate CRC in humans. Using these mouse models, scientific breakthroughs have been made on the understanding of the pathogenesis of this complex disease. Moreover, the availability of transgenic knock-in or knock-out mice further increases the potential of CRC mouse models. In this review, the overall features of carcinogen-induced (focusing on azoxymethane and azoxymethane/dextran sulfate sodium) and transgenic (focusing on ) mouse models, as well as their mechanisms to induce colon tumorigenesis, are explored. We also discuss limitations of these mouse models and their applications in the evaluation and study of drugs and treatment regimens against CRC. Through these mouse models, a better understanding of colon tumorigenesis can be achieved, thereby facilitating the discovery of novel therapeutic strategies against CRC.

Citing Articles

Model systems to study tumor-microbiome interactions in early-onset colorectal cancer.

Richter K, Wrage M, Krekeler C, De Oliveira T, Conradi L, Menck K EMBO Mol Med. 2025; 17(3):395-413.

PMID: 39948421 PMC: 11903813. DOI: 10.1038/s44321-025-00198-3.


The role of interleukin-17 in inflammation-related cancers.

Zhang X, Li B, Lan T, Chiari C, Ye X, Wang K Front Immunol. 2025; 15:1479505.

PMID: 39906741 PMC: 11790576. DOI: 10.3389/fimmu.2024.1479505.


Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions.

Sharma S, Singh N, Turk A, Wan I, Guttikonda A, Dong J World J Gastroenterol. 2024; 30(13):1815-1835.

PMID: 38659481 PMC: 11036501. DOI: 10.3748/wjg.v30.i13.1815.


Colorectal cancer murine models: Initiation to metastasis.

Pothuraju R, Khan I, Jain M, Bouvet M, Malafa M, Roy H Cancer Lett. 2024; 587:216704.

PMID: 38360138 PMC: 11257378. DOI: 10.1016/j.canlet.2024.216704.


Broccoli Cultivated with Deep Sea Water Mineral Fertilizer Enhances Anti-Cancer and Anti-Inflammatory Effects of AOM/DSS-Induced Colorectal Cancer in C57BL/6N Mice.

Lee Y, Pan Y, Lim D, Park S, Sin S, Kwack K Int J Mol Sci. 2024; 25(3).

PMID: 38338927 PMC: 10855752. DOI: 10.3390/ijms25031650.


References
1.
Paulsen J, Loberg E, Olstorn H, Knutsen H, Steffensen I, Alexander J . Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat. Cancer Res. 2005; 65(1):121-9. View

2.
Liang X, Li H, Tian G, Li S . Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer. Sci Rep. 2014; 4:4985. PMC: 4021569. DOI: 10.1038/srep04985. View

3.
Liang J, Nagahashi M, Kim E, Harikumar K, Yamada A, Huang W . Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell. 2013; 23(1):107-20. PMC: 3578577. DOI: 10.1016/j.ccr.2012.11.013. View

4.
Grady W . Genetic testing for high-risk colon cancer patients. Gastroenterology. 2003; 124(6):1574-94. DOI: 10.1016/s0016-5085(03)00376-7. View

5.
Neufert C, Becker C, Neurath M . An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc. 2007; 2(8):1998-2004. DOI: 10.1038/nprot.2007.279. View